Intentional obesity reduction and the occurrence of gastric cancer – literature review
DOI:
https://doi.org/10.12775/JEHS.2023.20.01.019Keywords
cancer, gastric cancer, bariatric surgery, prevention, obesity, survival in gastric cancerAbstract
Introduction: Gastric cancer (GC) is one of most common cancers worldwide. Reducing exposure to risk factors, along with screening and early detection, are crucial for prevention. Many studies have linked obesity to GC. Weight loss can be achieved through proper diet and exercise. For patients with a body mass index (BMI) of 40 or higher, or 35 or higher with serious obesity-related comorbidities, bariatric surgery can be a means of weight reduction. This raises the question of whether intentional weight loss can lower the risk of GC in the population.
Purpose of the study: The aim of this study is to collect and summarize existing evidence on connection of bariatric surgery and lower GC risk and mortality in patients with obesity.
Material and method: Literature review was performed, in English databases, using keywords : cancer, gastric cancer, bariatric surgery, prevention, obesity, survival in gastric cancer.
Results and conclusion: It is widely recognized that obesity increases the risk of GC, and bariatric surgery is an effective method for weight reduction. Bariatric surgery is the most effective treatment for sustained weight loss and remission of obesity-related conditions. A systematic review conducted on this topic revealed that bariatric surgery is linked to a reduced risk of GC in patients with obesity. Compared to no surgery, bariatric surgery was found to be associated with significantly lower rates of obesity-associated cancer and cancer-related mortality. Weight loss after bariatric surgery provides significant health benefits.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022 Mar 28;28(12):1187-1203. doi: 10.3748/wjg.v28.i12.1187. PMID: 35431510; PMCID: PMC8968487.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593.
Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016 Nov 26;388(10060):2654-2664. doi: 10.1016/S0140-6736(16)30354-3. Epub 2016 May 5. PMID: 27156933.
Zhang J, Su XQ, Wu XJ, Liu YH, Wang H, Zong XN, Wang Y, Ji JF. Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol. 2003 Dec;9(12):2658-61. doi: 10.3748/wjg.v9.i12.2658. PMID: 14669307; PMCID: PMC4612026.
Bruno DS, Berger NA. Impact of bariatric surgery on cancer risk reduction. Ann Transl Med. 2020 Mar;8(Suppl 1):S13. doi: 10.21037/atm.2019.09.26. PMID: 32309417; PMCID: PMC7154324.
Asplund J, Kauppila JH, Mattsson F, Lagergren J. Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden. Ann Surg Oncol. 2018 Sep;25(9):2693-2702. doi: 10.1245/s10434-018-6627-y. Epub 2018 Jul 9. PMID: 29987609; PMCID: PMC6097732.
Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018 Feb 7;10:239-248. doi: 10.2147/CMAR.S149619. PMID: 29445300; PMCID: PMC5808709.
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K; International Agency for Research on Cancer Handbook Working Group. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016 Aug 25;375(8):794-8. doi: 10.1056/NEJMsr1606602. PMID: 27557308; PMCID: PMC6754861.
Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):872-8. doi: 10.1158/1055-9965.EPI-05-0860. PMID: 16702363.
Xu YXZ, Mishra S. Obesity-Linked Cancers: Current Knowledge, Challenges and Limitations in Mechanistic Studies and Rodent Models. Cancers (Basel). 2018 Dec 18;10(12):523. doi: 10.3390/cancers10120523. PMID: 30567335; PMCID: PMC6316427.
Paz-Filho G, Lim EL, Wong ML, Licinio J. Associations between adipokines and obesity-related cancer. Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1634-50. doi: 10.2741/3810. PMID: 21196253.
Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA. 2019 Oct 1;322(13):1271-1282. doi: 10.1001/jama.2019.14231. PMID: 31475297; PMCID: PMC6724187.
Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes Obes Metab. 2011 Dec;13(12):1063-72. doi: 10.1111/j.1463-1326.2011.01464.x. PMID: 21733057.
Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev. 2009 Nov;10(6):610-6. doi: 10.1111/j.1467-789X.2009.00607.x. Epub 2009 Jun 12. PMID: 19527447.
Maciejewski ML, Arterburn DE, Van Scoyoc L, Smith VA, Yancy WS Jr, Weidenbacher HJ, Livingston EH, Olsen MK. Bariatric Surgery and Long-term Durability of Weight Loss. JAMA Surg. 2016 Nov 1;151(11):1046-1055. doi: 10.1001/jamasurg.2016.2317. PMID: 27579793; PMCID: PMC5112115.
Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. 2019 Mar;92:121-135. doi: 10.1016/j.metabol.2018.11.001. Epub 2018 Nov 13. PMID: 30445141.
Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, Gutierrez JM, Frogley SJ, Ibele AR, Brinton EA, Hopkins PN, McKinlay R, Simper SC, Hunt SC. Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med. 2017 Sep 21;377(12):1143-1155. doi: 10.1056/NEJMoa1700459. PMID: 28930514; PMCID: PMC5737957.
Murphy N, Jenab M, Gunter MJ. Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):659-670. doi: 10.1038/s41575-018-0038-1. PMID: 29970888.
Zhang K, Luo Y, Dai H, Deng Z. Effects of Bariatric Surgery on Cancer Risk: Evidence from Meta-analysis. Obes Surg. 2020 Apr;30(4):1265-1272. doi: 10.1007/s11695-019-04368-4. PMID: 31865552.
MacKintosh ML, Derbyshire AE, McVey RJ, Bolton J, Nickkho-Amiry M, Higgins CL, Kamieniorz M, Pemberton PW, Kirmani BH, Ahmed B, Syed AA, Ammori BJ, Renehan AG, Kitchener HC, Crosbie EJ. The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk. Int J Cancer. 2019 Feb 1;144(3):641-650. doi: 10.1002/ijc.31913. Epub 2018 Nov 20. PMID: 30289975; PMCID: PMC6519061.
Mackenzie H, Markar SR, Askari A, Faiz O, Hull M, Purkayastha S, Møller H, Lagergren J. Obesity surgery and risk of cancer. Br J Surg. 2018 Nov;105(12):1650-1657. doi: 10.1002/bjs.10914. Epub 2018 Jul 13. PMID: 30003539.
Schauer DP, Feigelson HS, Koebnick C, Caan B, Weinmann S, Leonard AC, Powers JD, Yenumula PR, Arterburn DE. Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort. Ann Surg. 2019 Jan;269(1):95-101. doi: 10.1097/SLA.0000000000002525. PMID: 28938270; PMCID: PMC6201282.
Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA. 2020 Sep 1;324(9):879-887. doi: 10.1001/jama.2020.12567. PMID: 32870301.
Aminian A, Wilson R, Al-Kurd A, Tu C, Milinovich A, Kroh M, Rosenthal RJ, Brethauer SA, Schauer PR, Kattan MW, Brown JC, Berger NA, Abraham J, Nissen SE. Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity. JAMA. 2022 Jun 28;327(24):2423-2433. doi: 10.1001/jama.2022.9009. PMID: 35657620; PMCID: PMC9166218.
Lazzati A, Epaud S, Ortala M, Katsahian S, Lanoy E. Effect of bariatric surgery on cancer risk: results from an emulated target trial using population-based data. Br J Surg. 2022 Apr 19;109(5):433-438. doi: 10.1093/bjs/znac003. PMID: 35136932.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jakub Gryta, Alicja Bielak, Karolina Iwan, Martyna Janczewska, Konrad Kania, Maria Kalicka, Tomasz Krysa, Agata Kolasa, Zuzanna Radziejowska, Magdalena Szklarz

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 258
Number of citations: 0